Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects. We are focused on treating pain locally – at its source. Our products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. Our first product, which recently completed its first clinical trial, is a rapidly acting topical analgesic to alleviate pain associated with venipuncture, venous cannulation and minor dermatological procedures. Our next products will focus on treating wound pain and localized inflammatory pain.
Houston, US
Vapogenix was founded in 2006 and is headquartered in Houston, US
Report incorrect company information

Vapogenix Office Locations

Vapogenix has an office in Houston
Houston, US (HQ)
Suite 170
Show all (1)
Report incorrect company information

Vapogenix Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$21.4 m

Latest funding size

$8.20 m

Time since last funding

2 years ago


Vapogenix's latest funding round in December 2016 was reported to be $8.2 m. In total, Vapogenix has raised $21.4 m
Show all financial metrics
Report incorrect company information